Rare diseases
Investigational molecules
Locations
453 conditions with trials, the busiest first
1 389 trials across Europe, recruiting first
Study on Bevacizumab for Patients with Symptomatic Cerebral Arteriovenous Malformations
FranceStudy on the Early Use of Risdiplam for Children with Spinal Muscular Atrophy After Gene Therapy
GermanyStudy on the Safety and Effects of Fosigotifator in Adults and Children with Vanishing White Matter Disease
The NetherlandsStudy on Lomustine with or without Additional Brain Radiation for Patients with Recurrent Glioblastoma
AustriaStudy on Fasudil Hydrochloride for Memory Loss Prevention in Early Alzheimer's Disease Patients
NorwayStudy on the Effectiveness and Safety of KarXT for Treating Psychosis in Patients with Alzheimer's Disease
BelgiumStudy on the Effects of Ketamine on Therapy Intensity and Brain Pressure in Patients with Traumatic Brain Injury
BelgiumStudy of Crizotinib and Temsirolimus for Children with ALK, ROS1, or MET Positive Cancers, Including Neuroblastoma and Rhabdomyosarcoma
DenmarkLong-term Safety Study of Delandistrogene Moxeparvovec for Patients with Duchenne Muscular Dystrophy Who Previously Received SRP-9001
BelgiumStudy on Early Immunotherapy with Human Normal Immunoglobulin, Cyclophosphamide, and Methylprednisolone for Patients with Anti-Hu Paraneoplastic Sensory Neuropathy
FranceStudy on the Safety of VX-670 for Adults with Myotonic Dystrophy Type 1
BelgiumStudy on the Safety and Dosage of GD2IL18CART for Patients with Relapsed or Refractory GD2 Positive Solid Cancers
GermanyThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
